Nephrectomy
Conditions
Keywords
erector spinae block, nephrectomy, ultrasound
Brief summary
The main purpose of this study is to evaluate the postoperative effect of erector spinae block in patients undergoing nephrectomy that causes both visceral and somatic pain.
Detailed description
After being informed and potential risks about the study, all patients have given written consent will undergo 24 hours screening for the analgesic effect of erector spinae block after nephrectomy. Patients meeting the criteria were randomly selected in double-blind manner 1:1 ratio to erector spiane block or not.
Interventions
PROCEDUREerector spinae block (ESP)
Administration of local anesthetic under the erector spinae muscle just below the transverse process of the thoracic 12th vertebra
Sponsors
Namik Kemal University
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Intervention model description
It is a single centre, randomized, prospective method comparison study.
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
1. To undergo partial or total nephrectomy surgery 2. To be in ASA I-II classification 3. To be between the ages of 18-65. 4. Not having problems that prevent erector spinae block application such as local anesthetic drug allergy, infection at the injection site, and structural anomaly. 5. Being in good mental and psychological health 6. To accept to participate in the study.
Exclusion criteria
1. Being in ASA III or IV class with a high risk of anesthesia 2. Being outside the age range of 18-65 3. Having problems such as local anesthetic drug allergy, infection at the injection site, and structural anomaly prevents block application. 4. Not being mentally and psychologically healthy 5. Those who are allergic to the active substance, patients using antiepileptic drugs 6. Those with severe hepatic and renal failure 7. Those who have long-term use of nonsteroidal anti-inflammatory and opioid analgesic, 8. Those with diabetes and other neuropathic diseases 9. Patients who cannot use patient-controlled analgesia (PCA) device
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Numerical Rating Scale (NRS) | 24 hours | Numerical Rating Scale (NRS) will be used for postoperative evaluation. NRS is a segmented digital version of the visual analog scale. Selecting an integer (0-10 integers) by a responder in (VAS). It is accepted as one dimensional-the measure of pain intensity in adults. The 11-point numerical scale ranges from 0 to 10, representing a pain (no pain). 10 (as bad pain as you can imagine), or (the worst pain imaginable). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Recovery analgesia | 24 hours | Secondary outcome measures will be routine (paracetamol or tramadol PCA) or recovery. Analgesic use will be recorded within the first 24 hours. |
| postoperative nausea and vomiting | 24 hours | The severity of nausea and vomiting 4-point scale (none, mild, moderate, and severe). As will be recorded by the nurses in the ward. |
Countries
Turkey (Türkiye)
Outcome results
None listed